Displaying items by tag: UAB Comprehensive Diabetes Center
UAB Heersink School of Medicine staff council representatives have officially been named for the 2022-2024 term. See who has been elected to represent you!
Tagged under
Three School of Medicine faculty projects were recently funded as AMC21 2019 Multi-PI awardees.
Tagged under
Inhibition of this microRNA might improve response to newer diabetes drugs, such as Byetta, Victoza, Trulicity, Januvia, Onglyza and Tradjenta.
Tagged under
A multidisciplinary research team at UAB looks to address obesity as it is genetically passed from mother to child.
Tagged under
Recruitment for the trial continues as Myers discusses the benefits she received from participating and the knowledge she has gained to take control of her health care.
Tagged under
Lead author of paper published in Diabetes Research and Clinical Practice journal says, while causal relationship cannot be inferred, findings are “absolutely encouraging.”
Tagged under
Many patients diagnosed with type 1 diabetes as adults do not fit the standard profile for a diabetes diagnosis; they are younger, are relatively fit and have little if any belly fat.
Tagged under
Three-year grant establishes consortium to better organize and support collaborative research related to the loss of functional beta cell mass in type 1 diabetes.
Tagged under
In human clinical trial, UAB to test drug shown to completely reverse diabetes in human islets, mice
The “repurposing of verapamil as a beta cell survival therapy in type 1 diabetes” trial will test an approach different from any current diabetes treatment.
Tagged under
African-Americans have higher obesity rates than do whites, and while socioeconomic status is often believed to be the root cause, a new UAB study suggests other factors should be considered.
Tagged under